Founded in 1994, it is one of the top ten brands of feed additives, a privately-held high-tech enterprise mainly producing and selling feed chlortetracycline and animal health products
Jinhe Biotechnology Co., Ltd. is a private holding enterprise mainly engaged in the production and sales of feed chlortetracycline and animal health products, which was recognized as a "national key high-tech enterprise" by the State Science and Technology Commission in 1998 and one of the 60 key enterprises in Inner Mongolia Autonomous Region. The company is located in Tuoketuo County, Inner Mongolia, at the southern foot of the green mountains and on the shore of the Yellow River, adjacent to the largest thermal power plant in Asia, the Datang Tuoketuo Power Plant, and across the (Yellow) River from China's largest open-pit coal mine, the Zungar Coalfield, with unique geographical and resource advantages.
The company now has the world's most advanced fermentation production equipment and product quality testing equipment, the main process flow is all controlled by microcomputer automation, the existing fermentation tonnage is 5794 cubic meters, and the fermentation scale of chlortetracycline ranks among the top in the world. Its leading products "Muxing" and "Jinhe" brand feed chlortetracycline currently have an annual production capacity of more than 53,000 tons, and have successfully passed the quality acceptance of the Food and Drug Administration (FDA) of the U.S. federal government for seven consecutive times. The products are mainly exported to the United States, Canada, Southeast Asia and other countries and regions, and the marketing network covers all provinces, municipalities (autonomous regions) in China, and the market prospect is very broad.
As a high-tech enterprise, Jinhe Biotechnology Co., Ltd. has developed rapidly in recent years, which is mainly due to the company's people-oriented development ideas and strong technical support. Through the introduction of talents and the rational allocation of human resources, the enterprise has gradually formed its own talent echelon, and at the same time giving full play to the group effect of talent advantages, it has continuously improved and innovated in the field of production technology, which has laid a solid foundation for the emergence of enterprises in the era of knowledge economy.
Good reputation and excellent quality come from the company's strict management and tireless pursuit of technological innovation. From 2001 to 2002, the company successfully passed the ISO9002 quality system certification and the GMP acceptance of the national veterinary drug enterprise.
Since 1994, the company has successfully passed the quality acceptance of the Food and Drug Administration (FDA) of the U.S. federal government for seven consecutive times, and has been recognized as a national key leading enterprise in agricultural industrialization by nine national ministries and commissions.
In the future development process, Jinhe Biotechnology Co., Ltd. will follow the development concept of "market-oriented, optimize structure, integrate resources, and improve efficiency", take the fermentation industry as the carrier, adjust the product structure as the main line, and take the road of strengthening the enterprise with science and technology that combines extension and connotation to expand reproduction, and realize asset optimization and management upgrading through the alliance with industry elites, and comprehensively improve the overall quality and core competitiveness of the enterprise in combination with the exploration and research of high-tech means such as genetic engineering. We should further enhance the economic strength and development stamina of enterprises and make new and greater contributions to the prosperity and development of national industry.
